The new branding and the latest prototypes for mdprostate and mdknee created a lot of awareness at the German Congress of Radiology in May. Last week mediaire presented its future portfolio and latest scientific evidence on international stage in Vienna from July 13 – 17.

Radiologists from all over the world showed keen interest in the new prototypes, but were also particularly impressed by the latest studies on the established mdbrain solution. The results clearly showed how reliable, precise and efficient the tool works in daily clinical practice.

Andreas Lemke, CEO of mediaire, summarizes the event as follows:”The ECR was an outstanding success for the entire team and shows that mediaire is on the right track. Especially with the new portfolio strategy aiming for coverage and outstanding quality.”